Connection
Michael Graner to Antineoplastic Agents
This is a "connection" page, showing publications Michael Graner has written about Antineoplastic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.777 |
|
|
|
-
Graner MW. Making HSP90 Inhibitors Great Again? Unite for Better Cancer Immunotherapy. Cell Chem Biol. 2021 02 18; 28(2):118-120.
Score: 0.356
-
Graner MW. HSP90 and Immune Modulation in Cancer. Adv Cancer Res. 2016; 129:191-224.
Score: 0.247
-
Smyth T, Kullberg M, Malik N, Smith-Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor-derived exosomes. J Control Release. 2015 Feb 10; 199:145-55.
Score: 0.058
-
Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, Bigner DD. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009 May; 23(5):1541-57.
Score: 0.038
-
Ramanathapuram LV, Hahn T, Graner MW, Katsanis E, Akporiaye ET. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines. Cancer Immunol Immunother. 2006 Feb; 55(2):166-77.
Score: 0.030
-
Zeng Y, Graner MW, Feng H, Li G, Katsanis E. Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia. Int J Cancer. 2004 Jun 10; 110(2):251-9.
Score: 0.028
-
Betker JL, Angle BM, Graner MW, Anchordoquy TJ. The Potential of Exosomes From Cow Milk for Oral Delivery. J Pharm Sci. 2019 04; 108(4):1496-1505.
Score: 0.019